Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. 2012

Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
Thermo Fisher Scientific, BRIMS (Biomarker Research in Mass Spectrometry), Cambridge, Massachusetts 02139, United States. amol.prakash@thermofisher.com

Over the past few years, mass spectrometry has emerged as a technology to complement and potentially replace standard immunoassays in routine clinical core laboratories. Application of mass spectrometry to protein and peptide measurement can provide advantages including high sensitivity, the ability to multiplex analytes, and high specificity at the amino acid sequence level. In our previous study, we demonstrated excellent reproducibility of mass spectrometry-selective reaction monitoring (MS-SRM) assays when applying standardized standard operating procedures (SOPs) to measure synthetic peptides in a complex sample, as lack of reproducibility has been a frequent criticism leveled at the use of mass spectrometers in the clinical laboratory compared to immunoassays. Furthermore, an important caveat of SRM-based assays for proteins is that many low-abundance analytes require some type of enrichment before detection with MS. This adds a level of complexity to the procedure and the potential for irreproducibility increases, especially across different laboratories with different operators. The purpose of this study was to test the interlaboratory reproducibility of SRM assays with various upfront enrichment strategies and different types of clinical samples (representing real-world body fluids commonly encountered in routine clinical laboratories). Three different, previously published enrichment strategies for low-abundance analytes and a no-enrichment strategy for high-abundance analytes were tested across four different laboratories using different liquid chromatography-SRM (LC-SRM) platforms and previously developed SOPs. The results demonstrated that these assays were indeed reproducible with coefficients of variation of less than 30% for the measurement of important clinical proteins across all four laboratories in real world samples.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D001774 Blood Chemical Analysis An examination of chemicals in the blood. Analysis, Blood Chemical,Chemical Analysis, Blood,Analyses, Blood Chemical,Blood Chemical Analyses,Chemical Analyses, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
February 2022, mSphere,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
June 2012, Molecular & cellular proteomics : MCP,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
October 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
January 2018, Analytical and bioanalytical chemistry,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
April 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
January 2014, Lipids in health and disease,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
November 2017, Analytical chemistry,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
January 2018, Communications biology,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
August 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Amol Prakash, and Taha Rezai, and Bryan Krastins, and David Sarracino, and Michael Athanas, and Paul Russo, and Hui Zhang, and Yuan Tian, and Yan Li, and Vathany Kulasingam, and Andrei Drabovich, and Christopher R Smith, and Ihor Batruch, and Paul E Oran, and Claudia Fredolini, and Alessandra Luchini, and Lance Liotta, and Emanuel Petricoin, and Eleftherios P Diamandis, and Daniel W Chan, and Randall Nelson, and Mary F Lopez
March 2022, Scientific reports,
Copied contents to your clipboard!